Neogen Stock (NASDAQ:NEOG)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$9.17

52W Range

$4.56 - $11.43

50D Avg

$9.18

200D Avg

$8.01

Market Cap

$2.01B

Avg Vol (3M)

$2.58M

Beta

1.80

Div Yield

-

NEOG Company Profile


Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

2,917

IPO Date

Aug 23, 1989

Website

NEOG Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceMay 25May 24May 23
Product$797.32M$821.82M$715.08M
Service$97.35M$102.40M$107.37M

Fiscal year ends in May 25 | Currency in USD

NEOG Financial Summary


May 25May 24May 23
Revenue$894.66M$924.22M$822.45M
Operating Income$-1.06B$58.66M$37.52M
Net Income$-1.09B$-9.42M$-22.87M
EBITDA$-1.06B$182.60M$122.30M
Basic EPS$-5.03$-0.04$-0.12
Diluted EPS$-5.03$-0.04$-0.12

Fiscal year ends in May 25 | Currency in USD

Latest Earnings Call Transcripts


Q3 26Apr 09, 26 | 12:00 AM
Q2 26Jan 08, 26 | 8:00 AM
Q1 26Oct 09, 25 | 8:00 AM

Peer Comparison


TickerCompany
KMTSKestra Medical Technologies, Ltd.
CNMDCONMED Corporation
TLRYTilray Brands, Inc.
UPBUpstream Bio, Inc.
BLFSBioLife Solutions, Inc.
NTLAIntellia Therapeutics, Inc.
OPKOPKO Health, Inc.
AZTAAzenta, Inc.
NVCRNovoCure Limited
ZBIOZenas BioPharma, Inc.